Health Condition 1: C508- Malignant neoplasm of overlappingsites of breast
Conditions
Interventions
None listed
Sponsors
RAJINDER PARSHAD
Eligibility
Inclusion criteria
Inclusion criteria: 1) Newly Diagnosed breast cancer patients enrolled in surgery 3 breast cancer clinic (BCC) will be included in the prospective group. 2) Diagnosed cases of carcinoma breast enrolled in surgery 3 BCC from January 2014 till start of study whose blocks and slides can be retrieved and follow up data available will be included in retrospective group. 3) Consenting to participate
Exclusion criteria
Exclusion criteria: 1) Blocks not available for review in retrospective patients 2) Patients with incomplete data 3) Patients not giving participation consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the expression of Tumour infiltrating lymphocytes and their correlation with standard prognostic factorsTimepoint: 3 monthly for the first two years after surgery followed by 6 monthly till the end of 5 years and then yearly after that . | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the correlation between tumour infiltrating lymphocytes and 2 year disease free survivalTimepoint: 2014 - 2020;To study the correlation between tumour infiltrating lymphocytes expression and response to NACT Timepoint: ETHICS APPROVAL TILL 2020 | — |
Countries
India
Contacts
Public ContactESHAN VERMA
ALL INDIA INSTITUTE OF MEDICAL SCIENCES
Outcome results
None listed